The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1197
December 6, 2004
View Complete Issue         Table of Contents 2019 
Drugs for Percutaneous Coronary Interventions
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Percutaneous Coronary Interventions
December 6, 2004 (Issue: 1197)
Percutaneous coronary intervention (PCI), such as balloon angioplasty or stent placement, predisposes to subsequent thrombosis. The current pharmacologic approach to prevention of this problem combines an anticoagulant with one or more antiplatelet...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Percutaneous Coronary Interventions
Article code: 1197c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.